Based on our Pharmacor advisory service entitled Hypertension, Decision Resources is offering an exclusive analyst call entitled Hypertension: Does Novartis’s Tekturna Still Have What it Takes to Meet Expectations? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

This analyst call was held on June 10, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.